0

Gastrointestinal Cancer Collection
 1-17 of 17 Articles
ACP Journal Club |  15 July 2014
In persons at average risk, stool DNA tests had higher sensitivity than FIT for detecting colorectal cancer
Richard M. Hoffman, MD, MPH
Ann Intern Med. 2014;161(2):JC10. doi:10.7326/0003-4819-161-2-201407150-02010
ACP Journal Club |  21 January 2014
Annual or biennial FOBT screening reduced colorectal cancer mortality, but not all-cause mortality, at 30 years
Robert H. Fletcher, MD, MSc
Ann Intern Med. 2014;160(2):JC2. doi:10.7326/0003-4819-160-2-201401210-02002
ACP Journal Club |  18 June 2013
Automated reminders and increasing intense support increased uptake of colorectal cancer screening
Robert H. Fletcher, MD, MSc
Ann Intern Med. 2013;158(12):JC8. doi:10.7326/0003-4819-158-12-201306180-02008
ACP Journal Club |  20 November 2012
A single FIT (≥ 50 ng Hb/mL) detected 38% of screen-detected advanced colorectal neoplasia
Richard F. Logan, MD
Ann Intern Med. 2012;157(10):JC5-10. doi:10.7326/0003-4819-157-10-201211200-02010
ACP Journal Club |  18 September 2012
Flexible sigmoidoscopy screening reduced colorectal cancer incidence and mortality in older adults
Charles J. Kahi, MD, MSc, FACP, FACG, AGAF; Thomas F. Imperiale, MD, FACP, AGAF
Ann Intern Med. 2012;157(6):JC3-3. doi:10.7326/0003-4819-157-6-201209180-02003
ACP Journal Club |  21 February 2012
Immunochemical FOBT was accurate for detecting colorectal cancer but less so for other GI lesions
Robert H. Fletcher, MD, MSc
Ann Intern Med. 2012;156(4):JC2-10. doi:10.7326/0003-4819-156-4-201202210-02010
ACP Journal Club |  19 April 2011
Fecal immunochemical tests had better sensitivity for detecting colorectal neoplasia in aspirin users than in nonusers
James E. Allison, MD; Callum G. Fraser, PhD
Ann Intern Med. 2011;154(8):JC4-10. doi:10.7326/0003-4819-154-8-201104190-02010
ACP Journal Club |  15 March 2011
Meta-analysis: Aspirin reduces risk for colon cancer and related mortality at 20 years, particularly when taken for ≥ 5 years
Ronald Koretz, MD
Ann Intern Med. 2011;154(6):JC3-3. doi:10.7326/0003-4819-154-6-201103150-02003
ACP Journal Club |  21 December 2010
Use of bisphosphonates was not associated with increased risk for esophageal or gastric cancer
Lionel S. Lim, MD, MPH, FACP, FACPM
Ann Intern Med. 2010;153(12):JC6-12. doi:10.7326/0003-4819-153-12-201012210-02012
ACP Journal Club |  19 October 2010
Once-only flexible sigmoidoscopy screening reduced colorectal cancer incidence and mortality
Ronald L. Koretz, MD
Ann Intern Med. 2010;153(8):JC4-4. doi:10.7326/0003-4819-153-8-201010190-02004
ACP Journal Club |  19 October 2010
Colorectal cancer screening with fecal immunochemical testing had higher adherence than screening with guaiac-based FOBT
Harvey J. Murff, MD, MPH
Ann Intern Med. 2010;153(8):JC4-5. doi:10.7326/0003-4819-153-8-201010190-02005
ACP Journal Club |  15 June 2010
Immunochemical FOBT had higher participation and detection rates than guaiac-based FOBT for colorectal cancer screening
Robert H. Fletcher, MD, MSc
Ann Intern Med. 2010;152(12):JC6-2. doi:10.7326/0003-4819-152-12-201006150-02002
ACP Journal Club |  21 April 2009
Review: Individual alarm features have moderate-to-high specificity and low sensitivity for diagnosing colorectal cancer
Michael Solomon, MB, BCh, MSc, FRACS; Toufic El-Khoury, MB, BS, FRACS
Ann Intern Med. 2009;150(8):JC3-14. doi:10.7326/0003-4819-150-8-200904210-02014
ACP Journal Club |  21 April 2009
Review: Newer screening tests have varied sensitivity and moderate-to-high specificity for detecting colorectal cancer
Robert H. Fletcher, MD, MSc
Ann Intern Med. 2009;150(8):JC4-15. doi:10.7326/0003-4819-150-8-200904210-02015
ACP Journal Club |  18 November 2008
Eradication of H. pylori after endoscopic resection for early gastric cancer reduced risk for metachronous gastric cancer
Vincent Wai-Sun Wong, MD; Francis Ka-Leung Chan, MD
Ann Intern Med. 2008;149(10):JC5-12. doi:10.7326/0003-4819-149-10-200811180-02012
ACP Journal Club |  20 May 2008
Adjuvant chemotherapy increased survival in colorectal cancer patients with low recurrence risk
Ronald L. Koretz, MD
Ann Intern Med. 2008;148(10):JC3-6. doi:10.7326/0003-4819-148-10-200805200-02006
ACP Journal Club |  20 May 2008
Cetuximab improved overall survival in colorectal cancer patients in whom other treatments had failed
James Shaw, MD, MPH
Ann Intern Med. 2008;148(10):JC3-8. doi:10.7326/0003-4819-148-10-200805200-02008
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)